ArticleFrontiers in immunology2026
Multiomic profiling of canine immune and metabolic aging in a cohort of young and senior beagles.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Developing a comprehensive understanding of canine aging requires integration of immune, metabolic, and genetic changes across molecular layers. While high-throughput omics have been widely applied to human aging, canine studies have typically used single modalities or small cohorts, limiting systems-level insight, particularly for immune and metabolic aging. To address this gap, we generated a multiomic immune and metabolic aging reference in a cohort of senior and young beagle dogs. Methods: We performed untargeted serum metabolomics in 50 canines (25 senior and 25 young). Additionally, we collected clinical biomarkers and measured gene expression from whole blood using bulk RNA sequencing (bulk RNAseq) from a subset of 39 canines (19 senior, 20 young). We also leveraged single-cell RNA sequencing (scRNAseq) from peripheral blood mononuclear cells (PBMCs) on a subset of 30 canines (15 senior, 15 young). Results: Obtaining ~318,000 PBMC transcriptomes-comprising the largest canine single-cell dataset to date-we resolved 27 distinct immune populations. Age-associated shifts were characterized by loss of naïve lymphocytes with expansion of selected myeloid and Th1-like effector subsets. This was reinforced by remodeling across the transcriptome and metabolome, including coordinated suppression of cell-cycle, DNA repair, and mitochondrial pathways in adaptive immune cells, enrichment of inflammatory signaling in innate immune cells, and depletion of ether-linked lipids and other membrane-associated lipids in serum. To demonstrate the utility of this reference, we leveraged external resources to prioritize a set of candidate genes, including Discussion: These findings characterize the immunometabolic landscape of aging in canine blood, creating a blueprint for identifying interventions to promote healthy aging and longevity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.